Position in ENTA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$517,223
-$128,590 QoQ
Shares Held
40,952
0.0% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Informed Momentum Co LLC holds $107,449,045 across 43 Biotechnology names. ENTA ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
76,640 | $6,431,628 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
18,995 | $6,119,999 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
98,860 | $5,211,899 | |
| 4 | CELC |
Celcuity Inc.
|
43,591 | $4,975,476 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
50,122 | $4,874,364 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
121,928 | $4,693,008 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
26,566 | $4,490,185 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
16,483 | $4,257,888 |
All Filings in ENTA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $517,223 | 40,952 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $645,813 | 40,952 | Shares | Sole | 2026-02-12 | |
| 2021-12-31 | $2,306,140 | 30,839 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||